JOINN adheres to the purpose of "Serve for Drug Innovation,
Focus on Safety Assessments and Monitoring of Drugs Throughout Life Cycles"

(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2023, THE SECOND A SHARE CLASS MEETING OF 2024 AND THE SECOND H SHARE CLASS MEETING OF 2024; (2) DISTRIBUTION OF CASH DIVIDEND; AND (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION

(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2023, THE SECOND A SHARE CLASS MEETING OF 2024 AND THE SECOND H SHARE CLASS MEETING OF 2024; (2) DISTRIBUTION OF CASH DIVIDEND; AND (3) AMENDMENTS TO THE ARTICLES OF ASSOCIATION

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024

Form of Proxy for the Annual General Meeting

Form of Proxy for the Annual General Meeting

Form of Proxy for the Second H Share Class Meeting of 2024

Form of Proxy for the Second H Share Class Meeting of 2024

NOTICE OF THE ANNUAL GENERAL MEETING OF 2023

NOTICE OF THE ANNUAL GENERAL MEETING OF 2023

NOTICE OF THE SECOND H SHARE CLASS MEETING OF 2024

NOTICE OF THE SECOND H SHARE CLASS MEETING OF 2024

Notification Letter and Reply Form for Registered Shareholders

Notification Letter and Reply Form for Registered Shareholders

Notification Letter and Request Form for Non-Registered Shareholders

Notification Letter and Request Form for Non-Registered Shareholders

Final dividend in cash for the year ended December 31, 2023

Final dividend in cash for the year ended December 31, 2023

Leave us a message

Thank you for your attention to JOINN. Please fill in the information below, and we will contact you promptly.

Message

Message

top